The 420 patients enrolled in Cook’s randomized trial of its Zilver PTX drug-eluting peripheral stent include peripheral arterial disease patients treated in Germany, the US and Japan. The
According to the company, the product will be available soon in the UK and Germany, with several other European markets to follow by the end of the year
As vice president of business development, Dr Clausen, who has been a consultant to Cytomedix since May 2008, will be responsible for the coordination of the investigational new
Under the agreement GSK has exclusive options to license drug candidates from Cellzome’s kinase programs directed against four identified targets, and three additional targets to be jointly identified
The memorandum of understanding (MoU) between the Texas A&M System and Xoma covers programs for advancing healthcare research and technologies through the development of new methods, standards and
Mr Sheckler began his career with the Ross Division of Abbott Laboratories, selling nutritional and pharmaceutical products. During his time there, he served in a variety of sales
Designed to comply with the EMEA (European Medicines Agency) and FDA standards, this unit is expected to produce desensitization treatments for all markets, primarily in Europe and North
Ben Liu, founder and chief scientific officer of Plexigen, said: “We are very excited to have Bill Haas join Plexigen at this critical premarket point. Bill spent 18
Jack Kraeutler, CEO of Meridian Bioscience, said: “The effective global distribution of our rapid tests for infectious disease is one of Meridian’s key strategies. By working closely with
As previously announced, Lifeline has been working diligently with a prominent Asian university to further develop and enhance the company’s First Warning System. This patent application is said
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.